keyword
https://read.qxmd.com/read/38623948/investigating-disparities-in-hypopharyngeal-laryngeal-cancer-survival-in-florida-with-geospatial-mapping-analysis
#21
JOURNAL ARTICLE
Uche C Ezeh, Abdurrahman Al-Awady, Isabella Buitron, Ming Lee, Garrett Forman, Sophia Peifer, Alana Deo, Larissa Sweeny, Donald Weed, Erin K Kobetz, Isildinha M Reis, Elizabeth Franzmann
OBJECTIVE: Identify predictors of overall survival (OS) after hypopharyngeal/laryngeal cancer in Florida. MATERIAL AND METHODS: We conducted a retrospective cohort study using data from the Florida Cancer Data System (FCDS) on patients diagnosed with hypopharyngeal or laryngeal cancer from 2010-2017. Primary outcome was OS. Hazard ratios (HRs) were estimated from univariable and multivariable Cox regression models for OS. Data was analyzed from November 1, 2022, to June 30, 2023...
2024: Cancer Control: Journal of the Moffitt Cancer Center
https://read.qxmd.com/read/38623936/clonal-expansion-in-normal-tissues
#22
REVIEW
Hirona Maeda, Nobuyuki Kakiuchi
Cancer originates from a single ancestral cell that acquires a driver mutation, which confers a growth or survival advantage, followed by the acquisition of additional driver mutations by descendant cells. Recently, it has become evident that somatic cell mutations accumulate in normal tissues with aging and exposure to environmental factors, such as alcohol, smoking, and UV rays, increases the mutation rate. Clones harboring driver mutations expand with age, leading to tissue remodeling. Lineage analysis of myeloproliferative neoplasms and der(1;16)-positive breast cancer revealed that driver mutations were acquired early in our lives and that the development of cancer takes decades, unveiling the previously unknown early process of cancer development...
April 16, 2024: Cancer Science
https://read.qxmd.com/read/38623927/prognostic-value-of-pretreatment-systemic-immune-inflammation-index-in-patients-with-endometrial-cancer-a-meta-analysis
#23
REVIEW
Pengtian Ji, Junjun He
Background: The present work focused on evaluating the systemic immune-inflammation index (SII) for its role in predicting endometrial cancer (EC) patient prognosis by meta-analysis. Methods: SII's role in predicting the prognosis of EC patients was analyzed by calculating combined hazard ratios (HRs) and 95% CIs. Results: As revealed by combined analysis, an increased SII predicted poor overall survival (HR = 2.01; 95% CI = 1.58-2.57; p < 0.001) as well as inferior progression-free survival (HR = 1...
April 16, 2024: Biomarkers in Medicine
https://read.qxmd.com/read/38623838/efficacy-and-safety-of-novel-immune-checkpoint-inhibitor-based-combinations-versus-chemotherapy-as-first-line-treatment-for-patients-with-extensive-stage-small-cell-lung-cancer-a-network-meta-analysis
#24
JOURNAL ARTICLE
Chuang Yang, Tiantian Xuan, Qing Gong, Xin Dai, Chengjun Wang, Rongyu Zhang, Wen Zhao, Jian Wang, Weiming Yue, Jisheng Li
BACKGROUND: Patients with extensive-stage small cell lung cancer (ES-SCLC) have an exceptionally poor prognosis and immune checkpoint inhibitors (ICIs) combined with etoposide-platinum is recommended as standard first-line therapy. However, which combination pattern is the best still remains unknown. This network meta-analysis was performed to compare the efficacy and safety of currently available patterns including an antiangiogenic agent containing regimen and probed into the most appropriate therapy for patients...
April 16, 2024: Thoracic Cancer
https://read.qxmd.com/read/38623823/investigating-the-predictive-factors-of-thoracic-aortic-invasion-and-surgical-outcomes-in-patients-with-primary-lung-cancer-a-retrospective-study
#25
JOURNAL ARTICLE
Hideomi Ichinokawa, Kazuya Takamochi, Mariko Fukui, Aritoshi Hattori, Takeshi Matsunaga, Kenji Suzuki
BACKGROUND: This study aimed to investigate predictors of thoracic aortic invasion in lung cancer patients using preoperative clinical and imaging characteristics and elucidate surgical outcomes in cases of aortic invasion. METHODS: Of the 4751 lung cancer patients who underwent surgery at our hospital, we included 126 (6.8%) who underwent left-sided surgery and in whom tumor appeared to be in contact with the thoracic aorta on preoperative imaging. The patients were divided into two groups: group A, 23 patients (18%) who underwent combined aortic resection (+); group B, 103 patients (82%) who did not undergo combined aortic resection (-)...
April 16, 2024: Thoracic Cancer
https://read.qxmd.com/read/38623812/continuous-immunotherapy-beyond-progression-in-clinical-practice-for-small-cell-lung-cancer
#26
JOURNAL ARTICLE
Ken Yamamoto, Taira Ninomaru, Hideaki Okada, Katsuya Hirano, Temiko Shimada, Akito Hata
In non-small-cell lung cancer, continuous immune-checkpoint inhibitors (ICIs) beyond progression are often used in clinical practice. On the other hand, there is almost no data on whether the concept of continuous ICIs beyond progression can be adopted in small-cell lung cancer (SCLC). We describe the effectiveness of continuous ICIs beyond progression in SCLC. Medical courses of SCLC patients treated with chemo-immunotherapy were retrospectively reviewed at our hospital. The study included 36 patients with a median age of 73 years (range 46-83 years) who introduced chemo-immunotherapy between September 2019 and December 2022...
April 16, 2024: Thoracic Cancer
https://read.qxmd.com/read/38623761/systolic-blood-pressure-and-survival-to-very-old-age-results-from-the-women-s-health-initiative
#27
JOURNAL ARTICLE
Bernhard Haring, Chris A Andrews, Kathleen Hovey, Aladdin H Shadyab, Andrea LaCroix, Lisa Warsinger Martin, Milagros C Rosal, Lewis H Kuller, Elena Salmoirago-Blotcher, Nazmus Saquib, Patrick Koo, Deepika Laddu, Marcia L Stefanick, JoAnn E Manson, Sylvia Wassertheil-Smoller, Michael J LaMonte
BACKGROUND: The relationship between systolic blood pressure (SBP) and longevity is not fully understood. We aimed to determine which SBP levels in women ≥65 years of age with or without blood pressure medication were associated with the highest probability of surviving to 90 years of age. METHODS: The study population consisted of 16570 participants enrolled in the Women's Health Initiative who were eligible to survive to 90 years of age by February 28, 2020, without a history of cardiovascular disease, diabetes, or cancer...
April 16, 2024: Circulation
https://read.qxmd.com/read/38623593/igsf3-tissue-expression-in-squamous-cell-carcinoma-of-the-oropharynx-a-novel-tool-for-prognosis-assessment-in-hpv-related-and-hpv-unrelated-disease
#28
JOURNAL ARTICLE
Anni Sjöblom, Lauri Jouhi, Pirjo Laakkonen, Reija Randén-Brady, Jussi Tarkkanen, Caj Haglund, Petri Mattila, Timo Carpén, Jaana Hagström, Antti Mäkitie
Biomarkers are not broadly used in the management of head and neck cancers (HNCs). Biomarkers have been beneficial in the management of other cancers, however, not in HNCs. Therefore, we observed the immunopositivity of a novel biomarker called immunoglobulin superfamily member 3 (IGSF3) in tumor tissues in HPV-related and HPV-unrelated OPSCC. Two patient cohorts (C1 and C2) from separate time periods were available for this study (total N = 282). Both consisted of OPSCC patients treated at the Helsinki University Hospital (HUS, Helsinki, Finland) during 2000-2016...
April 16, 2024: APMIS: Acta Pathologica, Microbiologica, et Immunologica Scandinavica
https://read.qxmd.com/read/38623539/chitinase-3-like-1-expression-associated-with-lymphatic-metastasis-and-prognosis-in-urothelial-carcinoma-of-the%C3%A2-bladder
#29
JOURNAL ARTICLE
Bo Wang, Ke Chen, Mingchao Gao, Xi Sun, Wang He, Junyu Chen, Wenjuan Yang, Tenghao Yang, Haide Qin, Honglian Ruan, Hao Huang, Tianxin Lin, Jian Huang
OBJECTIVES: Lymphatic metastasis, an early stage of the metastasis process, is associated with adverse clinical outcomes in urothelial carcinoma of the bladder (UCB). However, the role of inflammation in triggering lymphatic metastasis remains unclear. METHODS: We employed an RNA-sequencing cohort ( n  = 50) from Sun Yat-Sen Memorial Hospital (SYMH) to identify the most highly upregulated inflammatory gene associated with lymphatic metastasis. Using immunohistochemistry and immunofluorescence analyses, we validated the association of the identified molecule with clinical features and prognosis in an independent UCB cohort ( n  = 244) from SYMH...
2024: Clinical & Translational Immunology
https://read.qxmd.com/read/38623468/the-role-of-infiltrated-t-lymphocyte-in-oral-squamous-cell-carcinoma-insights-into-clinicopathological-characteristics-and-prognosis
#30
JOURNAL ARTICLE
Wei Liao, Jiaxuan Lu, Yuyuan Xu, Chulin Yang, Hongjie Chen, Shaohang Cai, Lili Liu, Shuwei Chen
BACKGROUND: To compare and analyze the presence of CD4+ and CD8 + lymphocyte infiltrates in Oral squamous cell carcinoma (OSCC) tissue versus adjacent tissue and their clinical significance. METHODS: We enrolled a total of 152 patients diagnosed with OSCC, all of whom had confirmed diagnoses through pathological reports. Clinical and demographics data were extracted from medical records. Tissue microarrays were constructed and immunohistochemical staining for CD4 and CD8 was performed...
2024: Journal of Inflammation Research
https://read.qxmd.com/read/38623463/combination-of-t-cell-redirecting-strategies-with-a-bispecific-antibody-blocking-tgf-%C3%AE-and-pd-l1-enhances-antitumor-responses
#31
JOURNAL ARTICLE
Antonio Tapia-Galisteo, Iñigo Sánchez-Rodríguez, Javier Narbona, Patricia Iglesias-Hernández, Saray Aragón-García, Anaïs Jiménez-Reinoso, Marta Compte, Shaukat Khan, Takeshi Tsuda, Patrick Chames, Javier Lacadena, Luis Álvarez-Vallina, Laura Sanz
T cell-based immunotherapies for solid tumors have not achieved the clinical success observed in hematological malignancies, partially due to the immunosuppressive effect promoted by the tumor microenvironment, where PD-L1 and TGF-β play a pivotal role. However, durable responses to immune checkpoint inhibitors remain limited to a minority of patients, while TGF-β inhibitors have not reached the market yet. Here, we describe a bispecific antibody for dual blockade of PD-L1 and TFG-β, termed AxF (scFv)2 , under the premise that combination with T cell redirecting strategies would improve clinical benefit...
2024: Oncoimmunology
https://read.qxmd.com/read/38623240/using-machine-learning-methods-to-study-the-tumour-microenvironment-and-its-biomarkers-in-osteosarcoma-metastasis
#32
JOURNAL ARTICLE
Guangyuan Liu, Shaochun Wang, Jinhui Liu, Jiangli Zhang, Xiqing Pan, Xiao Fan, Tingting Shao, Yi Sun
BACKGROUND: The long-term prognosis for patients with osteosarcoma (OS) metastasis remains unfavourable, highlighting the urgent need for research that explores potential biomarkers using innovative methodologies. METHODS: This study explored potential biomarkers for OS metastasis by analysing data from the Cancer Genome Atlas Program (TCGA) and Gene Expression Omnibus (GEO) databases. The synthetic minority oversampling technique (SMOTE) was employed to tackle class imbalances, while genes were selected using four feature selection algorithms (Monte Carlo feature selection [MCFS], Borota, minimum-redundancy maximum-relevance [mRMR], and light gradient-boosting machine [LightGBM]) based on the gene expression matrix...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38623224/efficacy-of-aerobic-and-resistance-exercises-on-cancer-pain-a-meta-analysis-of-randomised-controlled-trials
#33
REVIEW
Philip D Austin, Wei Lee, Daniel Sj Costa, Alison Ritchie, Melanie R Lovell
PURPOSE: To evaluate effects of aerobic and resistance exercises for cancer-related pain in adults with and surviving cancer. Secondary objectives were to a) evaluate the effect of exercise on fatigue, psychological function, physical function, b) assess fidelity to exercise. DESIGN: A systematic search of MEDLINE, EMBASE, AMED, CINAHL and Cochrane Central Register of Controlled Trials was conducted to identify randomised controlled trials (RCTs) comparing aerobic and/or resistance exercise to control groups...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38623216/a-real-world-comparison-of-circulating-tumor-cells-in-breast-cancer-from-china-novel-device-ctc-counts-and-its-overall-survival
#34
JOURNAL ARTICLE
Feng Li, Jianbin Li, Yang Yuan, Huiqiang Zhang, Shaohua Zhang, Li Bian, Tao Wang, Zefei Jiang
BACKGROUND: Both CellSearch and CellCollector have been accepted as the proper devices to capture CTC by domestic approval department. However, there is little article about the comparison between these two devices around the world. Herein, we conducted the real-world study to compare with these two devices and to re-verify the efficacy of CTC counts. METHODS: Patients who meet the following points should be included in the analysis. 1. Female, aged 18 years or older; 2...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38623143/maximum-likelihood-estimation-for-shape-restricted-single-index-hazard-models
#35
JOURNAL ARTICLE
Jing Qin, Yifei Sun, Ao Yuan, Chiung-Yu Huang
Single-index models are becoming increasingly popular in many scientific applications as they offer the advantages of flexibility in regression modeling as well as interpretable covariate effects. In the context of survival analysis, the single-index hazards models are natural extensions of the Cox proportional hazards models. In this paper, we propose a novel estimation procedure for single-index hazard models under a monotone constraint of the index. We apply the profile likelihood method to obtain the semiparametric maximum likelihood estimator, where the novelty of the estimation procedure lies in estimating the unknown monotone link function by embedding the problem in isotonic regression with exponentially distributed random variables...
October 2023: Journal of Data Science: JDS
https://read.qxmd.com/read/38622975/heterogeneous-characterization-of-neutrophilic-cells-in-head-and-neck-cancers
#36
JOURNAL ARTICLE
Magdalena Fay, Paul E Clavijo, Clint T Allen
BACKGROUND: Neutrophilic cells are among the most abundant immune populations within the head and neck tumor microenvironment (TME) and harbor multiple mechanisms of immunosuppression. Despite these important features, neutrophilic cells may be underrepresented in contemporary studies that aim to comprehensively characterize the immune landscape of the TME due to discrepancies in tissue processing and analysis techniques. Here, we review the role of pathologically activated neutrophilic cells within the TME and pitfalls of various approaches used to study their frequency and function in clinical samples...
April 15, 2024: Head & Neck
https://read.qxmd.com/read/38622958/a-prospective-health-economic-evaluation-to-determine-the-productivity-loss-due-to-premature-mortality-from-oral-cancer-in-india
#37
JOURNAL ARTICLE
Arjun Singh, Richard Sullivan, Manasi Bavaskar, Rathan Shetty, Poonam Joshi, Sudhir Nair, Sudeep Gupta, Pankaj Chaturvedi, Rajendra Badwe
INTRODUCTION: India contributes two-thirds of the global mortality due to oral cancer and has a younger population at risk. The societal costs of this premature mortality are barely discussed. METHODS: Using the human capital approach, we aimed to estimate the productivity lost due to premature mortality, valued using individual socioeconomic data, related to oral cancer in India. A bottom-up approach was used to prospectively collect data of 100 consecutive patients with oral cancer treated between 2019 and 2020, with a follow-up of 36 months...
April 15, 2024: Head & Neck
https://read.qxmd.com/read/38622957/trimodal-therapy-vs-radical-cystectomy-in-patients-with-muscle-invasive-bladder-cancer-a-systematic-review-and-meta-analysis-of-comparative-studies
#38
REVIEW
Francesco Ditonno, Alessandro Veccia, Francesca Montanaro, Greta Pettenuzzo, Antonio Franco, Celeste Manfredi, Luca Triggiani, Cosimo De Nunzio, Marco De Sio, Mariangela Cerruto, Simone Crivellaro, Alexander Kutikov, Riccardo Autorino, Alessandro Antonelli
OBJECTIVE: To perform a systematic review and meta-analysis of trials comparing trimodal therapy (TMT) and radical cystectomy (RC), evaluating differences in terms of oncological outcomes, quality of life, and costs. MATERIALS AND METHODS: In July 2023, a literature search of multiple databases was conducted to identify studies analysing patients with cT2-4 N any M0 muscle-invasive bladder cancer (MIBC; Patients) receiving TMT (Intervention) compared to RC (Comparison), to evaluate survival outcomes, recurrence rates, costs, and quality of life (Outcomes)...
April 15, 2024: BJU International
https://read.qxmd.com/read/38622949/urolithin-a-affects-cellular-migration-and-modulates-matrix-metalloproteinase-expression-in-colorectal-cancer-cells
#39
JOURNAL ARTICLE
Mohammad S El-Wetidy, Mohamad I Rady, Islam Rady, Hamed Helal
Colorectal cancer (CRC) is the world's second most common gastrointestinal malignancy. Preventing tumor cell proliferation and dissemination is critical for patient survival. Polyphenols have a variety of health advantages and can help prevent cancer. The current study examined different cellular activities of the gut-microbiota metabolite urolithin A (UA) on several colon cancer cell lines. The results revealed that UA suppressed cell growth in a dose- and time-dependent manner. In the current investigation, UA substantially affected cell migration in the wound-healing experiment and greatly decreased the number of colonies generated in each CRC cell culture...
April 2024: Cell Biochemistry and Function
https://read.qxmd.com/read/38622898/impact-of-concurrent-medications-on-the-outcome-of-immunotherapy-in-non-small-cell-lung-carcinoma
#40
JOURNAL ARTICLE
Jun Yamada, Takafumi Fukui, Atsuhiko Yatani, Chihiro Mimura, Kiyoko Fukuda, Daisuke Hazama, Naoko Katsurada, Tatsuya Nagano, Masatsugu Yamamoto, Motoko Tachihara
BACKGROUND: There have been reports on the impact of concurrent drugs on the outcome of immunotherapy for non-small cell lung carcinoma (NSCLC). However, the effect of some drugs, such as antibiotics and nonsteroidal anti-inflammatory drugs (NSAIDs), has not been clarified in patients with NSCLC. In the present study, we aimed to assess the association between concurrent drugs and the outcomes of immune checkpoint inhibitors (ICIs) alone or in combination with chemotherapy for patients with advanced NSCLC...
April 15, 2024: Thoracic Cancer
keyword
keyword
11400
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.